Jiangsu Nhwa Pharmaceutical Co., LTD (SHE:002262)
22.33
+0.07 (0.31%)
Apr 29, 2025, 2:45 PM CST
SHE:002262 Revenue
Jiangsu Nhwa Pharmaceutical Co., LTD had revenue of 1.51B CNY in the quarter ending March 31, 2025, with 11.29% growth. This brings the company's revenue in the last twelve months to 5.85B, up 12.08% year-over-year. In the year 2024, Jiangsu Nhwa Pharmaceutical Co., LTD had annual revenue of 5.70B with 13.01% growth.
Revenue (ttm)
5.85B
Revenue Growth
+12.08%
P/S Ratio
3.87
Revenue / Employee
987.84K
Employees
5,923
Market Cap
22.62B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5.70B | 656.13M | 13.01% |
Dec 31, 2023 | 5.04B | 742.99M | 17.28% |
Jan 1, 2023 | 4.30B | 362.85M | 9.22% |
Jan 1, 2022 | 3.94B | 574.36M | 17.09% |
Dec 31, 2020 | 3.36B | -788.01M | -18.99% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 37.92B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.79B |
Aier Eye Hospital Group | 20.98B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.30B |
Yunnan Baiyao Group Co.,Ltd | 40.03B |